Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans.
第一作者:
Hanns-Ulrich,Marschall
第一单位:
Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. hanns-ulrich.marschall@medhs.ki.se
作者:
医学主题词
生物转运(Biological Transport);胆结石(Cholelithiasis);胆汁淤积, 肝内(Cholestasis, Intrahepatic);剂量效应关系, 药物(Dose-Response Relationship, Drug);用药计划表(Drug Administration Schedule);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);肝循环(Liver Circulation);男(雄)性(Male);中年人(Middle Aged);手术前护理(Preoperative Care);参考值(Reference Values);利福平(Rifampin);危险性评估(Risk Assessment);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome);熊脱氧胆酸(Ursodeoxycholic Acid)
DOI
10.1016/j.gastro.2005.05.009
PMID
16083704
发布时间
2014-11-20
- 浏览66
Gastroenterology
476-85页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



